‘Wearing Off’ Of MS Treatments Between Doses MStranslate July 1, 2024 Research, Treatments Research Summary: The patient-reported wearing-off phenomenon with monoclonal antibody treatments for multiple sclerosis One of the major developments in the treatment of multiple sclerosis has been the...
Retinoic Acid and Calcitriol May Promote Remyelination MStranslate June 25, 2024 Remyelination, Research, Treatments Research Summary: The combined administration of LNC-encapsulated retinoic acid and calcitriol stimulates oligodendrocyte progenitor cell differentiation in vitro and in vivo after intranasal...
Announcement: MS Research Comms Collaboration MStranslate May 15, 2024 Cambridge, Collaboration, Research We are excited to announce that MStranslate has established a new science communication collaboration with the Cambridge Clinical Multiple Sclerosis Research Group, based at the University of Cambridge in...
Is Vitamin B12 Important in Multiple Sclerosis? MStranslate December 20, 2023 Fingolimod, Research, Vitamin B12 2 Comments Research Summary: FTY720 requires vitamin B12-TCN2-CD320 signaling in astrocytes to reduce disease in an animal model of multiple sclerosis The treatment of multiple sclerosis has improved greatly over the...
BTK Inhibitors in the Treatment of MS MStranslate December 12, 2023 Clinical Trials, Research, Treatments What is Bruton’s Tyrosine Kinase (BTK)? Bruton’s Tyrosine Kinase, or BTK, is an enzyme in the body that plays a role in the activity of B cells. B cells, which are important cells in the immune system,...
MS Milan 2023: Daily Research Summary Videos MStranslate October 19, 2023 ACTRIMS, ECTRIMS, Research 1 Comment MS Milan 2023 was the 9th Joint ECTRIMS-ACTRIMS Meeting, coordinated by the European Congress for the Treatment and Research Into Multiple Sclerosis (ECTRIMS) and the Americas Committee for Treatment and...
Neural Stem Cell Transplantation for Progressive MS MStranslate March 28, 2023 Research, Stem Cells, Treatments 1 Comment Research Summary: Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study The treatment of progressive multiple sclerosis remains an unmet need. ...
COVID-19 Infection and Multiple Sclerosis MStranslate March 14, 2023 COVID-19, Infection, Research MStranslate co-founder, Brett Drummond, explores and explains a recently published research paper that has identified COVID-19 infection as a potential trigger for multiple sclerosis. While the outcomes of...
Remyelination in Multiple Sclerosis: New Insights MStranslate January 16, 2023 Dr Travis Stiles, ECTRIMS, Remyelination, Research 1 Comment Late in 2022, we published two new videos that provided insights on the topic of remyelination research in multiple sclerosis (MS). The first video was recorded at the European Committee for Treatment and...
The Value of Specialist Multiple Sclerosis Nurses MStranslate November 29, 2022 ECTRIMS, Research, Videos At the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Belinda Bardsley (Austin Health, Australia) presented on a research study that assessed the impact...
